论文部分内容阅读
71例高脂血症患者随机分为 :阿托伐他汀组 3 6例 ,每天 1 0mg ;舒降之组 3 5例 ,每天 1 0mg ;共治疗 8周。结果阿托伐他汀组TC从 ( 2 5 4 6± 3 5 4)mg/dl降至 ( 1 87 1± 68 1 )mg/dl;LDL -C从 ( 1 44 4± 2 2 4)mg/dl降至 ( 90 0± 2 2 4)mg/dl) ;TG从 ( 2 74 8± 89 3 )mg/dl降至 ( 1 92 9± 91 7)mg/dl) ;HDL -C从 ( 5 0 4± 1 5 1 )mg/dl上升至 ( 5 2 0± 1 4 4)mg/dl,上升不明显 (P >0 0 5 )。结论 :阿托伐他汀组降低TC、TG、LDL -C作用优于同剂量舒降之组 (P <0 0 0 5 )。
71 patients with hyperlipidemia were randomly divided into: atorvastatin group 36 cases, 10 mg daily; Shude group 35 cases, 10 mg daily; a total of 8 weeks. Results TC in atorvastatin group decreased from (12546 ± 354) mg / dl to (1871 ± 681) mg / dl and LDL-C decreased from (4444 ± 224) mg / dl to (90 0 ± 2 2 4) mg / dl); TG decreased from (2 74 8 ± 89 3) mg / dl to (1 92 9 ± 91 7) mg / dl) 0 4 ± 1 5 1) mg / dl increased to (52 0 ± 1 4 4) mg / dl with no significant increase (P 0 05). CONCLUSION: The effects of TC, TG and LDL-C in atorvastatin group are better than those in the same dosage group (P <0 05).